Sarissa Capital Management LP Long-Term Concentrated

Location: Greenwich, CT

CIK: 0001577524 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value: $802M (100.0% shares, 0.0% debt)

Holdings (13)

— ALLERGAN PLC 21.8%

Value $175M Shares 1,042,500 Est. Cost $153.51 Unrealized —

— MEDICINES CO. 19.1%

Value $153M Shares 4,202,000 Est. Cost $27.97 Unrealized —

BIIB BIOGEN INC. 18.7%

Value $150M Shares 643,000 Est. Cost $278.12 Unrealized -17.0%

IRWD IRONWOOD PHARMACEUTICALS INC. 13.3%

Value $106M Shares 9,718,000 Est. Cost $11.82 Unrealized -5.2%

INVA INNOVIVA INC. 11.3%

Value $90.88M Shares 6,242,000 Est. Cost $12.99 Unrealized +9.1%

— INTERCEPT PHARMACEUTICALS INC. 7.5%

Value $60.23M Shares 757,000 Est. Cost $89.56 Unrealized —

JAZZ JAZZ PHARMACEUTICALS PLC 3.5%

Value $28.01M Shares 196,500 Est. Cost $132.38 Unrealized +1.5%

PBYI PUMA BIOTECHNOLOGY INC. 2.2%

Value $18.01M Shares 1,417,000 Est. Cost $30.04 Unrealized -23.3%

— MERSANA THERAPEUTICS INC. 1.9%

Value $15.19M Shares 3,750,000 Est. Cost $5.26 Unrealized —

— CYCLERION THERAPEUTICS INC. 0.4%

Value $2.862M Shares 250,000 Est. Cost $11.45 Unrealized —

— REGULUS THERAPEUTICS INC. 0.3%

Value $2.314M Shares 1,851,851 Est. Cost $1.25 Unrealized —

— MIRATI THERAPEUTICS INC. 0.0%

Value $103K Shares 1,000 Est. Cost $42.00 Unrealized —

ABBV ABBVIE INC. 0.0%

Value $72,000 Shares 1,000 Est. Cost $38.85 Unrealized +52.9%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	ALLERGAN PLC	1,042,500	$175M	21.8%	$153.51	—	SHS	G0177J108
—	MEDICINES CO.	4,202,000	$153M	19.1%	$27.97	—	COM	584688105
BIIB	BIOGEN INC.	643,000	$150M	18.7%	$278.12	-17.0%	COM	09062X103
IRWD	IRONWOOD PHARMACEUTICALS INC.	9,718,000	$106M	13.3%	$11.82	-5.2%	COM CL A	46333X108
INVA	INNOVIVA INC.	6,242,000	$90.88M	11.3%	$12.99	+9.1%	COM	45781M101
—	INTERCEPT PHARMACEUTICALS INC.	757,000	$60.23M	7.5%	$89.56	—	COM	45845P108
JAZZ	JAZZ PHARMACEUTICALS PLC	196,500	$28.01M	3.5%	$132.38	+1.5%	SHS USD	G50871105
PBYI	PUMA BIOTECHNOLOGY INC.	1,417,000	$18.01M	2.2%	$30.04	-23.3%	COM	74587V107
—	MERSANA THERAPEUTICS INC.	3,750,000	$15.19M	1.9%	$5.26	—	COM	59045L106
—	CYCLERION THERAPEUTICS INC.	250,000	$2.862M	0.4%	$11.45	—	COM	23255M105
—	REGULUS THERAPEUTICS INC.	1,851,851	$2.314M	0.3%	$1.25	—	COM NEW	75915K200
—	MIRATI THERAPEUTICS INC.	1,000	$103K	0.0%	$42.00	—	COM	60468T105
ABBV	ABBVIE INC.	1,000	$72,000	0.0%	$38.85	+52.9%	COM	00287Y109